Organogenesis Holdings vs Orasure Technologies
Organogenesis Holdings is the larger business, with $564m of revenue in fiscal 2025 against $115m for Orasure Technologies (4.9 times as much). Organogenesis Holdings grew faster (17.0% against -38.1%). Organogenesis Holdings kept more of each dollar of sales as profit: a net margin of 6.6% against -59.8%. Organogenesis Holdings carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Organogenesis HoldingsORGO, 2025 | Orasure TechnologiesOSUR, 2025 |
|---|---|---|
| Revenue | $564m | $115m |
| Revenue growth | 17.0% | -38.1% |
| Net income | $37.0m | −$68.7m |
| Operating margin | 7.9% | -62.6% |
| Net margin | 6.6% | -59.8% |
| Return on equity | 13.2% | -18.3% |
| Free cash flow | −$24.5m | −$53.2m |
| Cash | $93.7m | $199m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $15.0m |
| Employees | 854 | 500 |
| Market value | $109m | $247m |
| Price vs our value range | — | — |
| Moat score | 56 (Moderate) | 34 (Weak) |
| Insider trades, 12 months | 2 buys, 4 sales | 8 buys, 0 sales |